{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:00:06Z","timestamp":1780678806928,"version":"3.54.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Traditional Medicine and Technology Program","award":["2025ZL103"],"award-info":[{"award-number":["2025ZL103"]}]},{"name":"Medical and Health Science Program of Zhejiang Province","award":["2025KY1190"],"award-info":[{"award-number":["2025KY1190"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:p>\n                    Jinkui Shenqi Wan (JKSQW) is a classical traditional Chinese medicine (TCM) formula used for diabetic kidney disease (DKD), but its molecular mechanisms remain incompletely defined. While non-coding RNAs (ncRNAs) are increasingly recognized as key regulators in DKD, their role in the therapeutic action of JKSQW has not been systematically explored. Accordingly, we aimed to elucidate the potential mechanisms of JKSQW in DKD by integrating a circRNA\u2013miRNA\u2013mRNA regulatory network into a network pharmacology framework. Bioactive constituents and putative targets of JKSQW were retrieved from TCMSP and STITCH and mapped to UniProt. DKD-related differentially expressed mRNAs (DEmRNAs) were obtained from GEO (GSE1009; GPL16791) and analyzed using DESeq2 (Benjamini\u2013Hochberg adjusted\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05; |log2FC|\u2005&gt;\u20052). circRNA\u2013miRNA interactions were predicted using miRcode and cross-checked with starBase when available; miRNA\u2013mRNA interactions were integrated from miRDB, miRTarBase, and TargetScan, retaining pairs supported by\u2005\u2265\u20052 resources or validated entries. Overlapping drug\u2013disease targets underwent STRING-based protein\u2013protein interaction (PPI) analysis, GO\/KEGG enrichment with clusterProfiler, and molecular docking (AutoDock Vina). Docked complexes were visualized in PyMOL and annotated with PLIP. Fifty constituents mapped to 218 targets; 543 DEmRNAs were identified in DKD, with 20 overlapping genes considered potential therapeutic targets. PPI analysis highlighted hubs HTR2A, EGFR, TOP2A, CDK1, and MYC. Integration of ncRNA predictions yielded a circRNA\u2013miRNA\u2013mRNA network comprising 50 circRNAs, 32 miRNAs, and 20 mRNAs, revealing axes such as circ_0000962\u2013miR\u201115a\u20115p\u2013CDK1. Enrichment implicated p53 and AGE\u2013RAGE signaling in apoptosis, fibrosis, and oxidative stress. Docking showed stigmasterol exhibited favorable affinities with HTR2A (\u22128.3 kcal\/mol), EGFR (\u22127.6), TOP2A (\u22127.8), and CDK1 (\u22128.7). JKSQW may exert multi-component, multi-target protection against DKD by engaging ncRNA-mediated regulation and protein hubs within p53 and AGE\u2013RAGE pathways. These findings provide a modern pharmacological rationale for this TCM formula and a transferable framework for ceRNA-integrated network analyses.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048377","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:02:13Z","timestamp":1776434533000},"page":"e48377","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Integrated analysis of the circRNA\u2013miRNA\u2013mRNA regulatory network underlying the therapeutic effects of Jinkui Shenqi Wan, a traditional Chinese medicine formula, in diabetic kidney disease: A network pharmacology and bioinformatics study"],"prefix":"10.1097","volume":"105","author":[{"given":"Yao","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingying","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5262-3424","authenticated-orcid":false,"given":"Peiwu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.3390\/ijms251810222","article-title":"Novel insights into diabetic kidney disease.","volume":"25","author":"M\u0142ynarska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"117745","DOI":"10.1016\/j.jep.2024.117745","article-title":"Jin-Gui-Shen-Qi Wan alleviates fibrosis in mouse diabetic nephropathy via MHC class II.","volume":"324","author":"Liang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"580834","DOI":"10.3389\/fcell.2021.580834","article-title":"Construction of circRNA-miRNA-mRNA network for exploring underlying mechanisms of lubrication disorder.","volume":"9","author":"Cong","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"2673890","DOI":"10.1155\/2022\/2673890","article-title":"Identification of the circRNA-miRNA-mRNA regulatory network in pterygium-associated conjunctival epithelium.","volume":"2022","author":"Yu","year":"2022","journal-title":"Biomed Res Int"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"e17550","DOI":"10.1016\/j.heliyon.2023.e17550","article-title":"Exploring the pharmacological mechanisms of Tripterygium wilfordii against diabetic kidney disease using network pharmacology and molecular docking.","volume":"9","author":"Lu","year":"2023","journal-title":"Heliyon"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"e23535","DOI":"10.1016\/j.heliyon.2023.e23535","article-title":"QiDiTangShen granules alleviates diabetic nephropathy podocyte injury: a network pharmacology study and experimental validation in vivo and vitro.","volume":"10","author":"Gao","year":"2024","journal-title":"Heliyon"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fgene.2019.00563","article-title":"MiR-30e-5p and MiR-15a-5p expressions in plasma and urine of type 1 diabetic patients with diabetic kidney disease.","volume":"10","author":"Dieter","year":"2019","journal-title":"Front Genet"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"6978984","DOI":"10.1155\/2017\/6978984","article-title":"Urinary exosomal MicroRNA profiling in incipient Type 2 diabetic kidney disease.","volume":"2017","author":"Xie","year":"2017","journal-title":"J Diabetes Res"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.3390\/ijms21197115","article-title":"Acute kidney injury in septic patients treated by selected nephrotoxic antibiotic agents-pathophysiology and biomarkers-A review.","volume":"21","author":"Petejova","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R11-20260605","first-page":"3060","article-title":"microRNA-15a-5p participates in sepsis by regulating the inflammatory response of macrophages and targeting TNIP2.","volume":"19","author":"Lou","year":"2020","journal-title":"Exp Ther Med"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","article-title":"AGE\/RAGE in diabetic kidney disease and ageing kidney.","volume":"171","author":"Wu","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/tox.23917","article-title":"N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","volume":"38","author":"Qin","year":"2023","journal-title":"Environ Toxicol"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"1047184","DOI":"10.3389\/fphar.2023.1047184","article-title":"Niaoduqing alleviates podocyte injury in high glucose model via regulating multiple targets and AGE\/RAGE pathway: network pharmacology and experimental validation.","volume":"14","author":"Fang","year":"2023","journal-title":"Front Pharmacol"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"8358102","DOI":"10.1155\/2020\/8358102","article-title":"Radix rehmanniae and corni fructus against diabetic nephropathy via AGE-RAGE signaling pathway.","volume":"2020","author":"Chen","year":"2020","journal-title":"J Diabetes Res"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12906-022-03662-6","article-title":"Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.","volume":"22","author":"Fu","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s10020-025-01138-0","article-title":"Empagliflozin ameliorates renal and metabolic derangements in obese type 2 diabetic mice by blocking advanced glycation end product-receptor axis.","volume":"31","author":"Matsui","year":"2025","journal-title":"Mol Med"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"22780","DOI":"10.1038\/s41598-025-04292-x","article-title":"Single nucleus RNA-seq reveals the process from onset to chronic kidney disease in IgA nephropathy.","volume":"15","author":"You","year":"2025","journal-title":"Sci Rep"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"ar141","DOI":"10.1091\/mbc.E23-12-0479","article-title":"Cyclin A\/Cdk1 promotes chromosome alignment and timely mitotic progression.","volume":"35","author":"Valles","year":"2024","journal-title":"Mol Biol Cell"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s12013-024-01620-2","article-title":"TOP2A promotes proliferation, migration, and inflammatory response in M5-treated keratinocytes by binding CTBP1 to activate Wnt\/\u03b2-catenin signaling.","volume":"83","author":"Yang","year":"2025","journal-title":"Cell Biochem Biophys"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"154040","DOI":"10.1016\/j.phymed.2022.154040","article-title":"Screening and evaluation of quality markers from Shuangshen Pingfei formula for idiopathic pulmonary fibrosis using network pharmacology and pharmacodynamic, phytochemical, and pharmacokinetic analyses.","volume":"100","author":"Yeqing","year":"2022","journal-title":"Phytomedicine"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2017.11.005","article-title":"TGF-\u03b21\/p53 signaling in renal fibrogenesis.","volume":"43","author":"Higgins","year":"2018","journal-title":"Cell Signal"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.3390\/ijms25158122","article-title":"Stigmasterol: an enigmatic plant stress sterol with versatile functions.","volume":"25","author":"Valitova","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R24-20260605","first-page":"1420","article-title":"Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK\/STAT signalling pathway.","volume":"23","author":"Li","year":"2018","journal-title":"J BUON"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s12013-024-01559-4","article-title":"\u03b2-sitosterol mitigates apoptosis, oxidative stress and inflammatory response by inactivating TLR4\/NF-\u043aB pathway in cell models of diabetic nephropathy.","volume":"83","author":"Yang","year":"2025","journal-title":"Cell Biochem Biophys"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1039\/D4FO06043A","article-title":"Dietary phytosterol supplementation mitigates renal fibrosis via activating mitophagy and modulating the gut microbiota.","volume":"16","author":"Yang","year":"2025","journal-title":"Food Funct"},{"key":"R27-20260605","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4093\/dmj.2025.0220","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists in diabetic kidney disease: evolving evidence and clinical application.","volume":"49","author":"Bae","year":"2025","journal-title":"Diabetes Metab J"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41581-021-00490-8","article-title":"Mineralocorticoid receptor antagonists in diabetic kidney disease \u2014 mechanistic and therapeutic effects.","volume":"18","author":"Barrera-Chimal","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/antiox13040455","article-title":"Oxidative stress: a culprit in the progression of diabetic kidney disease.","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxidants (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:01:45Z","timestamp":1780675305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048377","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2025-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}